• Ornithine aspartate and vitamin-E combination has beneficial effects on cardiovascular risk factors in an animal model of nonalcoholic fatty liver disease in rats 

      Freitas, Laura Bainy Rodrigues de; Longo, Larisse; Chiela, Eduardo Cremonese Filippi; Souza, Valessa Emanoele Gabriel de; Behrens, Luiza Marques Prates; Pereira, Matheus Henrique Mariano; Leonhard, Luiza Cecília; Zanettini, Giulianna; Pinzon, Carlos Eduardo; Luchese, Eduardo Dal-Lomo; Lima, Guilherme Jorge Semmelmann Pereira; Cerski, Carlos Thadeu Schmidt; Cruz, Carolina Uribe; Álvares-da-Silva, Mário Reis (2022) [Artigo de periódico]
      Cardiovascular (CV) disease is the main cause of death in nonalcoholic fatty liver disease (NAFLD), a clinical condition without any approved pharmacological therapy. Thus, we investigated the effects of ornithine aspartate ...